VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Return
24.65%
This Quarter Return
+3.07%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$1.62M
AUM Growth
-$789M
(-100%)
Cap. Flow
-$127M
Cap. Flow
% of AUM
-7,850.43%
Top 10 Holdings %
Top 10 Hldgs %
16.56%
Holding
402
New
38
Increased
331
Reduced
2
Closed
31
Top Buys
| 1 |
Elbit Systems
ESLT
|
$181K |
| 2 |
Amazon
AMZN
|
$12.6K |
| 3 |
Microsoft
MSFT
|
$9.56K |
| 4 |
AGN
Allergan plc
AGN
|
$6.81K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$6.66K |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$91.8M |
| 2 |
HNT
HEALTH NET INC
HNT
|
$2.13M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$1.93M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.48M |
| 5 |
Duke Energy
DUK
|
$1.47M |
Sector Composition
| 1 | Industrials | 19.96% |
| 2 | Technology | 12.84% |
| 3 | Financials | 11.72% |
| 4 | Healthcare | 11.37% |
| 5 | Consumer Discretionary | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYAD
351
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
| $966 | 0.06% |
21,872
+6,690
| +44% | +$295 |
|
|
IMDZ
352
DELISTED
Immune Design Corp.
IMDZ
| $956 | 0.06% |
73,608
+35,224
| +92% | +$457 |
|
353
CytomX Therapeutics
CTMX
$348M
| $952 | 0.06% |
73,830
+35,328
| +92% | +$456 |
|
|
KITE
354
DELISTED
Kite Pharma, Inc.
KITE
| $940 | 0.06% |
20,466
+9,494
| +87% | +$436 |
|
355
MKS Inc. Common Stock
MKSI
$6.92B
| $902 | 0.06% |
23,980
+11,652
| +95% | +$438 |
|
356
Iovance Biotherapeutics
IOVA
$861M
| $898 | 0.06% |
176,720
+84,567
| +92% | +$430 |
|
357
MacroGenics
MGNX
$133M
| $858 | 0.05% |
45,742
+21,890
| +92% | +$411 |
|
358
Atara Biotherapeutics
ATRA
$88.8M
| $802 | 0.05% |
1,687
+787
| +87% | +$374 |
|
359
Baidu
BIDU
$34.5B
| $750 | 0.05% |
3,926
+2,608
| +198% | +$498 |
|
360
ImmunityBio
IBRX
$2.29B
| $744 | 0.05% |
90,444
+42,208
| +88% | +$347 |
|
|
LUMO
361
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $718 | 0.04% |
4,388
+2,048
| +88% | +$335 |
|
|
BLCM
362
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $708 | 0.04% |
7,574
+3,534
| +87% | +$330 |
|
363
Teva Pharmaceuticals
TEVA
$21.5B
| $682 | 0.04% |
12,734
+9,121
| +252% | +$488 |
|
364
Waste Management
WM
$88.9B
| $642 | 0.04% |
10,886
+2,606
| +31% | +$154 |
|
365
UGI
UGI
$7.39B
| $638 | 0.04% |
15,812
+7,684
| +95% | +$310 |
|
|
KDNY
366
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $602 | 0.04% |
9,392
+4,383
| +88% | +$281 |
|
367
Celldex Therapeutics
CLDX
$1.53B
| $350 | 0.02% |
6,180
+2,884
| +88% | +$163 |
|
|
MRO
368
DELISTED
Marathon Oil Corporation
MRO
| $248 | 0.02% |
22,220
+11,788
| +113% | +$132 |
|
369
Freeport-McMoran
FCX
$66.2B
| $226 | 0.01% |
21,908
+3,989
| +22% | +$41 |
|
|
S
370
DELISTED
Sprint Corporation
S
| $202 | 0.01% |
57,834
+29,688
| +105% | +$104 |
|
|
VER
371
DELISTED
VEREIT, Inc.
VER
| $190 | 0.01% |
4,287
+1,096
| +34% | +$49 |
|
372
Bath & Body Works
BBWI
$6.34B
| – | – |
-17,765
| Closed | -$1.38M |
|
373
Biogen
BIIB
$20.9B
| – | – |
-4,708
| Closed | -$1.44M |
|
374
Booking.com
BKNG
$179B
| – | – |
-1,026
| Closed | -$1.31M |
|
375
Builders FirstSource
BLDR
$16.2B
| – | – |
-98,376
| Closed | -$1.09M |
|